Studies on the participation of the dopaminergic system in the central effects of chelidonine. 1990

Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
Department of Pharmacology Medical Academy, Lublin, Poland.

Chelidonine administered to rats in doses of 25, 50, 100 and 200 mg/kg ip exerted an inhibitory effect on the dopaminergic structures in the rat. It was shown that chelidonine decreased amphetamine- and apomorphine-induced hyperactivity and inhibited amphetamine and apomorphine sterotype. Besides, chelidonine significantly inhibited the yawning and penile erection produced by apomorphine. However, chelidonine potentiated also catalepsy caused by haloperidol. In doses of 100 and 200 mg/kg ip chelidonine depressed the whole brain dopamine (DA) concentrations and enhanced DA utilization.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010410 Penile Erection The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions. Tumescence, Penile,Nocturnal Penile Tumescence,Penile Tumescence,Erection, Penile,Penile Tumescence, Nocturnal,Tumescence, Nocturnal Penile
D010617 Phenanthridines
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D002492 Central Nervous System Depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). CNS Depressants,Depressants, CNS
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug

Related Publications

Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
January 1983, Polish journal of pharmacology and pharmacy,
Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
January 1980, Polish journal of pharmacology and pharmacy,
Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
July 2001, Neurotoxicity research,
Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
July 1982, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
July 2001, Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova,
Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
July 1989, Japanese journal of pharmacology,
Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
April 1988, Pharmacology, biochemistry, and behavior,
Z Kleinrok, and J Szponar, and B Matuszek, and E Jagiełło-Wójtowicz
September 1984, Toxicology and applied pharmacology,
Copied contents to your clipboard!